Around 97% of patients with advanced pancreatic cancer die within five years. Researchers have figured out a way to target ...

New research shows a medication called daraxonrasib is helping people with advanced pancreatic cancer live longer.

Patients in El Paso with certain abdominal cancers now have access to a highly specialized treatment option closer to home ...

Novel gedatolisib is currently under review at FDA for wild-type patients ...

Immunotherapy wipes out some colorectal tumors without surgery, signaling a major shift toward less invasive treatment.

For decades, pancreatic cancer has been one of the most lethal cancers, with few effective treatment options. A new drug, daraxonrasib, targets the KRAS mutation that fuels most pancreatic ...

Advanced screenings and longevity assessments are gaining traction in preventive health. But the value is more nuanced, according to Mayo Clinic’s Dr. Liz Gilman. In this Q&A, she shares where these ...

For patients with advanced cancer, an app-facilitated palliative care intervention helps to maintain health-related quality ...

Izalontamab brengitecan more than doubled PFS compared with chemotherapy ...

An experimental pill helped people with one of the most deadly cancers in the world live longer, researchers reported this ...

Enthusiasm is growing for daraxonrasib, a new pancreatic cancer drug showing unprecedented results in clinical trials by ...